# Sonia A. Veluchamy

> Sonia A. Veluchamy is the Chicago-area CEO and co-founder of Celegence, a regulatory consulting and technology company she launched with her sister, Punya Abbhi, in 2017. After nearly a decade running operations at ArisGlobal, Veluchamy built Celegence around a practical thesis: life-sciences companies need regulatory expertise, disciplined data governance, and carefully applied automation in the same room. The company later acquired Qdossier, developed the CAPTIS AI platform, and in 2024 its CAPTIS team won TOPRA's Innovation Award. In 2025, Crain's Chicago Business named Veluchamy among its Notable Leaders in Health Care Technology.

- **Role:** CEO and Co-Founder at Celegence
- **Organizations:** Celegence, ArisGlobal, Commit2Change, LAUNCH U, YPO Chicago Chapter, The Economic Club of Chicago
- **Nationality:** American
- **Education:** BA in Economics, University of Chicago, MBA in Finance and Entrepreneurship, Columbia Business School
- **Known for:** Co-founded Celegence in 2017 and led it as CEO., As Managing Director at ArisGlobal, expanded its customer base to 30 of the top 50 global pharmaceutical companies, according to Celegence., Led Celegence during its 2022 acquisition of Qdossier.

## Career timeline

- **2005-2020** — Served as a board member and founding mentor with LAUNCH U.
- **2009-2017** — Worked as Managing Director at ArisGlobal, leading operations and expanding its customer base to 30 of the top 50 global pharmaceutical companies.
- **2015-2019** — Served as a board member at ArisGlobal.
- **2017** — Co-founded Celegence with her sister, Punya Abbhi, and became CEO.
- **2022** — Led Celegence through its acquisition of Qdossier, expanding the company's global footprint and dossier-management capabilities.
- **2024** — Joined the board of Commit2Change; Celegence's CAPTIS team won TOPRA's Innovation Award.
- **2025** — Named one of Crain's Chicago Business' Notable Leaders in Health Care Technology.
- **2026** — Listed among the Celegence leaders attending RAPS Convergence 2026, where the company planned to discuss defensible AI-assisted regulatory evidence work.

## Achievements

- Co-founded Celegence in 2017 and led it as CEO.
- As Managing Director at ArisGlobal, expanded its customer base to 30 of the top 50 global pharmaceutical companies, according to Celegence.
- Led Celegence during its 2022 acquisition of Qdossier.
- Led Celegence when its CAPTIS team won TOPRA's 2024 Innovation Award.
- Recognized by Crain's Chicago Business as a 2025 Notable Leader in Health Care Technology.
- Served for 15 years as a board member and founding mentor of LAUNCH U.
- Joined the Commit2Change board in 2024.

## Latest updates

- **2026-09** — Celegence listed Veluchamy among its leaders attending RAPS Convergence 2026 in Charlotte, where the company planned to discuss responsible AI and defensible regulatory evidence synthesis.
- **2025-10** — Crain's Chicago Business named Veluchamy among its 2025 Notable Leaders in Health Care Technology.
- **2025-08** — Celegence appeared on the 2025 Inc. 5000; the company reported 117% three-year growth.
- **2025-04** — Veluchamy appeared on pharmaphorum's podcast to discuss intelligent regulatory compliance and the pressure on regulatory teams.
- **2024-11** — Veluchamy joined the Empowered Patient Podcast to discuss data governance, regulatory complexity and technology adoption in the medical-device sector.

## Links

- Website: https://www.celegence.com/teams/sonia-veluchamy/
- LinkedIn: https://www.linkedin.com/in/soniaveluchamy

---

Profile page: https://yespress.io/sonia-veluchamy
Published by YesPress — https://yespress.io
Last updated: 2026-08-25